SMBPX vs. SHPAX

Last updated Jun 3, 2026

SMBPX (Saratoga Municipal Bond Portfolio) and SHPAX (Saratoga Health & Biotechnology Fund) are both mutual funds - SMBPX is a Ultrashort Bond fund managed by Saratoga, while SHPAX is a Health & Biotech Equities fund managed by Saratoga. Over the past 10 years, SMBPX returned -0.15%/yr vs 6.14%/yr for SHPAX. At a correlation of -0.03, they often move in opposite directions. SMBPX charges 3.16%/yr vs 2.90%/yr for SHPAX.

Performance

SMBPX vs. SHPAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Saratoga Municipal Bond Portfolio (SMBPX) and Saratoga Health & Biotechnology Fund (SHPAX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

Over the past 10 years, SMBPX has underperformed SHPAX with an annualized return of -0.15%, while SHPAX has yielded a comparatively higher 6.14% annualized return.

SMBPX

• 1D: 0.00%
• 1M: 0.00%
• YTD: 0.00%
• 6M: -0.23%
• 1Y: 3.99%
• 3Y*: 1.73%
• 5Y*: 0.17%
• 10Y*: -0.15%

SHPAX

• 1D: -1.71%
• 1M: -0.53%
• YTD: -2.63%
• 6M: -2.69%
• 1Y: 13.38%
• 3Y*: 6.68%
• 5Y*: 4.92%
• 10Y*: 6.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

SMBPX vs. SHPAX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
SMBPX Saratoga Municipal Bond Portfolio	0.00%	2.92%	-0.11%	1.84%	-2.57%	-1.39%	0.77%	1.00%	-2.38%	2.12%
SHPAX Saratoga Health & Biotechnology Fund	-2.63%	17.43%	0.26%	-0.36%	1.93%	16.71%	3.52%	27.67%	-5.30%	11.78%

Correlation

The correlation between SMBPX and SHPAX is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (10Y) Calculated over the trailing 10-year period	0.04
Correlation (All Time) Calculated using the full available price history since Jan 4, 2000	-0.03

The correlation between SMBPX and SHPAX shifts across timeframes, from -0.03 (all time) to 0.09 (3 years), reflecting how their relationship changes across market environments.

Return for Risk

SMBPX vs. SHPAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMBPX

SMBPX Risk / Return Rank: 93
SMBPX Sharpe Ratio Rank: 89
SMBPX Sortino Ratio Rank: 96
SMBPX Omega Ratio Rank: 98
SMBPX Calmar Ratio Rank: 96
SMBPX Martin Ratio Rank: 83

SHPAX

SHPAX Risk / Return Rank: 13
SHPAX Sharpe Ratio Rank: 12
SHPAX Sortino Ratio Rank: 12
SHPAX Omega Ratio Rank: 11
SHPAX Calmar Ratio Rank: 17
SHPAX Martin Ratio Rank: 12

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMBPX vs. SHPAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Saratoga Municipal Bond Portfolio (SMBPX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SMBPX	SHPAX	Difference
Sharpe ratio Return per unit of total volatility	2.91	0.95	+1.97
Sortino ratio Return per unit of downside risk	5.57	1.43	+4.13
Omega ratio Gain probability vs. loss probability	2.09	1.17	+0.92
Calmar ratio Return relative to maximum drawdown	6.52	1.51	+5.00
Martin ratio Return relative to average drawdown	15.86	3.66	+12.20
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SMBPX vs. SHPAX - Sharpe Ratio Comparison

The current SMBPX Sharpe Ratio is 2.91, which is higher than the SHPAX Sharpe Ratio of 0.95. The chart below compares the historical Sharpe Ratios of SMBPX and SHPAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SMBPX	SHPAX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.91	0.95	+1.97
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.08	0.35	-0.27
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.08	0.37	-0.45
Sharpe Ratio (All Time) Calculated using the full available price history	0.88	0.29	+0.58

Drawdowns

SMBPX vs. SHPAX - Drawdown Comparison

The maximum SMBPX drawdown since its inception was -9.99%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for SMBPX and SHPAX.

Drawdown Indicators

	SMBPX	SHPAX	Difference
Max Drawdown Largest peak-to-trough decline	-9.99%	-69.50%	+59.51%
Max Drawdown (1Y) Largest decline over 1 year	-0.69%	-8.45%	+7.76%
Max Drawdown (3Y) Largest decline over 3 years	-4.48%	-16.32%	+11.84%
Max Drawdown (5Y) Largest decline over 5 years	-6.52%	-16.32%	+9.80%
Max Drawdown (10Y) Largest decline over 10 years	-9.99%	-28.05%	+18.06%
Current Drawdown Current decline from peak	-2.99%	-8.40%	+5.41%
Average Drawdown Average peak-to-trough decline	-2.47%	-27.93%	+25.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.28%	3.49%	-3.21%

Volatility

SMBPX vs. SHPAX - Volatility Comparison

The current volatility for Saratoga Municipal Bond Portfolio (SMBPX) is 0.00%, while Saratoga Health & Biotechnology Fund (SHPAX) has a volatility of 3.62%. This indicates that SMBPX experiences smaller price fluctuations and is considered to be less risky than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SMBPX	SHPAX	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	3.62%	-3.62%
Volatility (6M) Calculated over the trailing 6-month period	0.39%	10.04%	-9.65%
Volatility (1Y) Calculated over the trailing 1-year period	1.43%	14.13%	-12.70%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	2.21%	14.27%	-12.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	1.96%	16.58%	-14.62%

SMBPX vs. SHPAX - Expense Ratio Comparison

SMBPX has a 3.16% expense ratio, which is higher than SHPAX's 2.90% expense ratio.

Dividends

SMBPX vs. SHPAX - Dividend Comparison

SMBPX's dividend yield for the trailing twelve months is around 2.69%, less than SHPAX's 3.76% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SHPAX Saratoga Health & Biotechnology Fund	3.76%	3.66%	1.35%	5.38%	6.34%	3.76%	13.82%	13.24%	22.00%	17.98%	12.52%	10.70%
SMBPX Saratoga Municipal Bond Portfolio	2.69%	2.69%	1.16%	0.00%	0.00%	0.04%	0.10%	0.10%	0.36%	0.23%	4.23%	1.50%

Frequently Asked Questions

Can I hold both SMBPX and SHPAX in my portfolio?

SMBPX and SHPAX have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SMBPX or SHPAX?

SHPAX has higher volatility (3.62%) compared to SMBPX (0.00%). In terms of maximum drawdown, SMBPX dropped -9.99% vs SHPAX's -69.50%.

Which has better risk-adjusted returns?

SMBPX currently has the higher Sharpe Ratio (2.91 vs 0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.